[ad_1]
Pfizer “final derivation of 95% prevention rate in phase 3 vaccine”
Of 170 infected patients, 8 were vaccinated and infected
“More than 94% of the prevention effect for people over 65”
Pfizer “plans to apply for emergency use approval from the FDA in a few days”
[앵커]
Pfizer, a US pharmaceutical company, said the end result was a 95% prevention rate in a phase 3 clinical trial of its COVID-19 vaccine. The Pfizer CEO told the US Food and Drug Administration that he would order emergency use of the Corona 19 vaccine in a few days. Reporter Seho Kim reports. The US pharmaceutical company Pfizer and the German Bioentech have revealed the final clinical results of the joint development of the COVID-19 vaccine. The foreign press reported at the same time that the prevention rate reached 95% in a phase 3 clinical trial of Pfizer’s Corona 19 vaccine at 18 local time. Pfizer looked at 170 Corona 19-infected patients among the participants in the phase 3 trial and found that only 8 cases received Corona 19 even after receiving a vaccine. The remaining 162 were patients who were prescribed the so-called placebo or fake drugs. “The preventive effect was consistent across the age, race and ethnicity maps,” Pfizer said. “The prevention effect exceeded 94% even for the elderly over 65. In addition, he added that the vaccine developed this time does not have serious side effects. Pfizer will apply for emergency use approval from the US Food and Drug Administration and the FDA in a few days. Pfizer’s announcement of the results was made 9 days after the announcement of the interim results on day 9 that the prevention rate was greater than 90% based on the analysis of 94 participants in the phase 3 clinical trial. On the 16th, a week after the announcement of Pfizer’s interim results, the US pharmaceutical company Modena announced an interim result that the prevention rate of the COVID-19 candidate vaccine being developed is 94.5%. Previously, unlike the Pfizer-Bioentech vaccine, the Modena vaccine could be stored in a general refrigerator, so it was evaluated that it would be much easier to distribute. Pfizer’s announcement of the final results came two days after Modena’s announcement. If the request for approval of emergency use by Pfizer and Modena is accepted by the FDA, the vaccines in the US, which have already signed a purchase contract for the Pfizer and Moderna vaccines, will be able to begin next month. This is YTN Seho Kim.
